Department of Clinical Laboratory, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Alcohol Clin Exp Res. 2020 May;44(5):1075-1087. doi: 10.1111/acer.14331. Epub 2020 Apr 21.
Alcoholic hepatitis (AH) is a severe inflammatory liver disease that develops in some heavy drinkers. AH patients have intense hepatic infiltration of leukocytes. Up-regulation of cell adhesion molecules (CAMs) upon endothelial cell (EC) activation plays an important role in leukocyte transendothelial migration. CAMs can shed from EC surface and accumulate in the blood, serving as soluble markers for EC activation. In this study, we examined the impact of heavy drinking on expression of soluble forms of EC activation markers (CD146, ICAM-1, VCAM-1, and VEGF-A) and the effect of alcohol abstinence on the reversal of these abnormalities in heavy drinkers with and without AH.
ELISA and multiplex immunoassays were used to measure soluble EC activation markers in plasma samples from 79 AH patients, 66 heavy drinkers without overt liver disease (HDC), and 44 healthy controls (HC) at baseline, 31 AH patients and 30 HDC at 6-month follow-up, and 18 AH patients and 25 HDC at 12-month follow-up.
At baseline, the 4 soluble markers were significantly up-regulated in AH patients compared with HDC and HC, whereas only sVCAM-1 was elevated in HDC relative to HC. At follow-ups, plasma levels of CD146, VCAM-1, and VEGF-A remained higher in AH patients, even for those who stopped drinking. These dysregulated markers correlated with AH disease severity, clinical parameters, and several soluble inflammatory factors.
The levels of soluble CD146, ICAM-1, VCAM-1, and VEGF-A were highly elevated in AH patients, and alcohol abstinence did not completely reverse these abnormalities.
酒精性肝炎(AH)是一种在一些重度饮酒者中发展的严重炎症性肝病。AH 患者的白细胞在肝脏中大量浸润。内皮细胞(EC)激活时细胞黏附分子(CAM)的上调在白细胞跨内皮迁移中起重要作用。CAM 可以从 EC 表面脱落并在血液中积累,作为 EC 激活的可溶性标志物。在这项研究中,我们研究了重度饮酒对可溶性 EC 激活标志物(CD146、ICAM-1、VCAM-1 和 VEGF-A)表达的影响,以及酒精戒断对 AH 和非 AH 重度饮酒者这些异常逆转的影响。
使用 ELISA 和多重免疫分析测定 79 例 AH 患者、66 例无明显肝脏疾病的重度饮酒者(HDC)和 44 例健康对照者(HC)的基线血浆样本中的可溶性 EC 激活标志物,以及 31 例 AH 患者和 30 例 HDC 患者的 6 个月随访和 18 例 AH 患者和 25 例 HDC 患者的 12 个月随访。
基线时,AH 患者的 4 种可溶性标志物均显著高于 HDC 和 HC,而 HDC 仅比 HC 升高 sVCAM-1。随访时,即使是那些已经戒酒的 AH 患者,CD146、VCAM-1 和 VEGF-A 的血浆水平仍然较高。这些失调的标志物与 AH 疾病严重程度、临床参数和几种可溶性炎症因子相关。
可溶性 CD146、ICAM-1、VCAM-1 和 VEGF-A 的水平在 AH 患者中显著升高,酒精戒断并不能完全逆转这些异常。